Advertisement

Topics

Puma Biotechnology Reports Fourth Quarter and Full Year 2016 Financial Results

16:20 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2016. Unless otherwise stated, all comparisons are for the fourth quar...

Other Sources for this Article

Puma Biotechnology, Inc.
Alan H. Auerbach or Mariann Ohanesian, +1 424 248 6500
info@pumabiotechnology.com
ir@pumabiotechnology.com
or
Russo Partners
David Schull or Darren Chia, +1 212 845 4226
david.schull@russopartnersllc.com
darren.chia@russopartnersllc.com

NEXT ARTICLE

More From BioPortfolio on "Puma Biotechnology Reports Fourth Quarter and Full Year 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...